Zusammenfassung
Die Harnwegsinfektion gehört zu den häufigsten bakteriellen Infektionen. Während davon betroffene Jungen in der Neonatalperiode bis zum 5. Lebensmonat dominieren, kehrt sich das Verhältnis in der Folgezeit um: In den ersten 5 Lebensjahren beträgt das Infektionsrisiko für Mädchen etwa 5%, für Jungen 1%. Bei über 50% der Kinder sind Infektrezidive zu erwarten. Reihenuntersuchungen ergaben bei 2% und mehr Schwangeren und bei 15–20% der Frauen über 70 Jahre eine Bakteriurie.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abraham SN, Babu JP, Biampapa CS (1985) Protection against Escherichia coli induced urinary tract infections with hybridoma antibodies directed against type I fimbriae or complementary D- mannose receptors. Infect Immun 48: 625–628
Agace W, Hedges S, Ceska M, Svanborg C (1993) IL-8 and the neutrophil response to mucosal Gram negative infection. J Clin Invest 92: 780–785
Agace WW, Patarroyo M, Svensson M, Carlemalm E, Svanborg C (1995) Escherichia coli induces trans-uroepithelial neutrophil migration by an ICAM-I dependent mechanism. Infect Immun 63: 4054–4062
Agace W, Connell H, Svanborg C (1996) Host resistance to urinary tract infection. In: Mobley HLT, Warren JW (eds) Urinary tract infections, molecular pathogenesis and clinical management. American Society for Microbiology, Washington, pp 221–243
Asscher AW, Sussman M, Waters WE, Davis RH, Chick S (1966) Urine as a medium for bacterial growth. Lancet 12 II: 1037–1041
Balish MJ, Jensen J, Uehlin DT (1982) Bladder mucin: a scanning electron microscopy study in experimental cystitis. J Urol 128: 1060–1062
Benson M, Andreasson A, Jodal U, Karlsson A, Rydberg J, Svanborg C (1994) Interleukin 6 in childhood urinary tract infection. Pediatr Infect Dis J 13: 612–616
Bergogne-Berezin E (1987) Bacterial host interaction in the pathogenesis of lower urinary tract infection. Eur Urol 13 [Suppl 1]: 37–41
Bibel DJ (1983) Competitive adherence as a mechanism of bacterial interference. Can J Microbiol 29: 700–703
Briese V (1987) Nachweis von Immunglobulinen im weiblichen Urogenitaltrakt und Kolostrum unter besonderer Berücksichtigung des sekretorischen Immunglobulin A (A-IgA). Z Klin Med 42: 1735–1736
Brooks S, Lyons J, Braude A (1974) Immunization against retrograde pyelonephritis. Am J Pathol 74: 345–354
Bruce AW (1983) Adherence of gram-negative uropathogenes to human uroepithelial cells. J Urol 130: 293–298
Brühl P (1993) Körpereigene Abwehrmechanismen der vesikalen Infektion. Urologe (B) 33: 289 - 293
Brühl P (1997) Harnwegsinfektionen. Urologe (B) 37: 327
Brühl P, Heinrich J (1990) Harnwegsinfektionen. Urologe (A) 29: W4–12
Brühl P, Tunn U (1967) Immunologische Aspekte der Pyelonephritis - die Bedeutung der unspezifischen Infektionsresistenz und der Immunität. Urologe 6: 37
Brühl P, Heinrich J, Hacker J (1992) Immuntherapie bei Harnwegsinfektionen, Urologe (A) 31: 37–42
Burdon D (1970) Quantitative studies of urinary immunoglobulins in hospital patients, including patients with urinary tract infection. Clin Exp Immunol 6: 189–196
Cerf-Bensussan N, Quaroni A, Kurnick J, Bhan A (1984) Intraepithelial lymphocytes modulate the expression by intestinal epithelial cells. J Immunol 132: 244–2252
Chambers S, Kunin C (1985) The osmoprotective properties of urine for bacteria: the protective effect of betaine and human urine against low pH and high concentrations of electrolytes, sugars and urea. J Infect Dis 152: 1308–1316
Chan RCY, Bruce AW, Reid G (1984) Adherence of cervical vaginal and distal urethral normal, microbial flora to human uroepithelial cells and the inhibition of adherence of Gram-negative uropathogens by competitive exclusion. J Urol 31: 596–601
Chan RCY, Reid G, Irvin RT, Bruce AW, Costerton JW (1985) Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 47: 84–89
Courtney H (1983) Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin. J Bacteriol 153: 763–770
Cox CE, Hinman F Jr. (1961) Experiments with induced bacteriuria, vesical emptying and bacterial growth on the mechanism of bladder defense to infection. J Urol 86: 739–748
Dialogues in Pediatric Urology (1986) Bacterial virulence factors in UTI. 9: 5
Dulawa J, Jann K, Thomsen M, Rambausek M, Ritz E (1988) Tamm-Horsfall glycoprotein interferes with bacterial adherence to human kidney cells. Eur J Clin Invest 18: 87–91
Eisenhauer PB, Harwig SL, Lehrer RI (1992) Cryptdins antimicrobial defensins of the murine small intestine. Infect Immun 60: 3556–3565
Falkenhagen U, Becziczka B, Gotthardt HJ, Speckin KU, Straube E (1986) Phagozytose bei Patienten mit chronischer Pyelonephritis. Z Urol Nephrol 79: 629–636
Fowler J, Stamey E (1977) Studies of introital colonization in women with recurrent urinary tract infection. VII. The role of bacterial adherence. J Urol 117: 472–476
Fünfstück R, Fuchs M, Stein G, Wessel G, Tietz U (1987) Untersuchungen über den Einfluß des Urins auf die Adhärenz von E. coli an Uroepithelzellen. Nieren Hochdruck 16: 479–486
Grischke EM, Rüttgers H (1987) Treatment of bacterial infections of the female urinary tract by immunization of the patients. Urol Int 42: 338–343
Gwynn MN, Webb LT, Rolinson GN (1981) Regrowth of Pseudomonas aeruginosa and other bacteria after the bactericidal action of carbenicillin and other beta-lactam antibiotics. J Infect Dis 144: 263–269
Hagberg L, Leffler H, Svanborg-Eden C (1984) Non-antibiotic prevention of urinary tract infection. Infection 12: 132–137
Hanson L, Tan E (1965) Characterization of antibodies in human urine. J Clin Invest 44: 703–715
Hanson L, Ahlstedt S, Fasth A (1977) Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections. J Infect Dis 135: 144–149
Hanson LA, Andersson B, Carlsson B et al. (1984) Defens of mucous membranes by antibodies, receptor analogues and non-specific host factors. Infection 12: 111–114
Hanson LA, Andersson B, Carlsson B et al. (1985) The secretory IgA system. Klin Pädiatr 197: 330–333
Harber MJ (1984) Virulence factors of E. coli. In: Losse H (ed) Pyelonephritis, vol 5. Thieme, Stuttgart, pp 43–50
Hasenbach J (1993) Urologe [B] 33: 318–322
Hedges S, Stenquist K, Lidin-Janson G, Martinell J, Sandberg T, Svanborg C (1992) Comparison of urine and serum concentrations of interleukin-6 in women with acute pyelonephritis or asymptomatic bacteriuria. J Infect Dis 166: 653–656
Hedges S, Bjarnadottir M, Agace W, Hang L, Svanborg C (1996) Immunoregulatory cytokines modify Escherichia coli induced epithelial cell IL-6 and IL-8 responses. Cytokine 8: 686–697
Herzenberg L (1975) Fluorescence-activated cell sorting. Sci Am 234: 108–117
Hinman F Jr., Cox CE (1996) The voiding vesical defense mechanism: the mathematical effect of residual urine, voiding interval and volume on bacteriuria. J Urol 96: 491–498
Hubmann R, Brühl P (1966) Ergebnisse der Langzeitbehandlung der chronischen Zysto-Pyelone- phritis. Urologe 5: 15–19
Kaack I, Pere MB, Korhonen TK, Svenson SB, Roberts JA (1989) P-fimbriae vaccines; 1. Cross reactive antibodies to heterologues P-fimbriae. Ped Nephrol 3: 386–390, 391–396
Källenius G, Jacobsen SH, Tullus K, Svenson SB (1985) P-fimbriae studies on the diagnosis and prevention of acute pyelonephritis. Infection 13 [Suppl 2]: 159–162
Kaijser B, Ahlstedt S (1977) Protective capacity of antibodies against Escherichia coli O and K antigens. Infect Immun 17: 286–289
Kass EH, Ziai M (1957) Methionine as a urinary antiseptic. In: Welch H, Marti-Ibanez F (eds) Antibiot Ann. Medical Encyclopedia, New York, pp 80
Kaye D (1968) Antibacterial activity of human urine. J Clin Invest 47: 2374–2390
Kinane DF (1982) ABO blood group: secretor state and susceptibility to current urinary tract infection in women. Br Med J 285: 7–9
Ko YC, Mukaida N, Ishiyama S, Tokue A, Kawai T, Matsushima K, Kasahara T (1993) Elevated inter- leukin-8 levels in the urine of patients with urinary tract infections. Infect Immun 61: 1307–1314
Kunin CM (1986) The prospects for a vaccine to prevent pyelonephritis. N Engl J Med 314: 514–515
Kunin CM (1997) Urinary tract infections: detection, prevention and management, 5th edn. Williams & Wilkens, London
Kvale D, Krajci P, Brandtzaeg P (1992) Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand J Immunol 35: 669–676
Lee J-Y, Boman A, Chuanxin S, Andersson M, Jörnvall H, Mutt V, Boman H (1989) Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci USA 86: 9159–9162
Lomberg H, Cedergren B, Leffler H, Nilsson B, Carlström A-S, Svanborg-Eden C (1986) Influence of blood group on the availability of receptors for attachment of uropathogenic Escherichia coli. Infect Immun 51: 919–926
Lomberg H, Jodal U, Leffler H, de Man P, Svanborg C (1992) Blood group non-secretors have an increased inflammatory response to urinary tract infection. Scand J Infect Dis 24: 77–83
Mackintosh JP, Watson BW, O’Grady F (1975) Theory of hydrokinetic clearance of bacteria from the urinary bladder. II. Effect of “bound” organisms and diuresis. Invest Urol 12: 473–478
Magasi P, Pánovics J, Illése A, Nagy M (1994) Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial. Eur J Urol 26: 137–140
Marx M, Weber M, Schafranek D, Wandel E, Meyer zum Büschenfelde K-H, Köhler H (1989) Secretory immunoglobulin A in urinary tract infection, chronic glomerulonephritis, and renal transplantation. Clin Immunol Immunopathol 53: 181–191
Misselwitz J (1986) Neuere Erkenntnisse auf einigen Gebieten der Harnwegsinfektion im Kindesalter. Z Ärztl Fortbild (Jena) 80: 411–414
Neumann G (1988) Regulationsfaktoren des vaginalen mikroökologischen Systems. Zbl Gynäkol 110: 405–412
Norden C, Green G, Kass E (1968) Antibacterial mechanism of the urinary bladder. J Clin Invest 47: 2689–2700
O’Grady F, Cattell WR (1966) Kinetics of urinary tract infection. Br J Urol 38: 156–162
O’Hanley P (1996) Prospects for urinary tract infection vaccines. In: Mobley et al. (eds) Urinary tract infections: molecular pathogenesis and clinical management. ASM, Washington
Parsons CL (1986) Pathogenesis of urinary tract infections. Bacterial adherence, bladder defense mechanisms. Urol Clin North Am 13: 563–568
Pattersson-Delafield J, Martinez R, Lehrer R (1980) Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infect Immun 30: 180–192
Retzke U, Graf H, Brühl P (1997) Die Harnweginfektionen der Frau. Ärztebl Thüring 8: 45–50, 88–91
Riedasch G, Möhring K (1986) Immunisierungstherapie rezidivierender Harnwegsinfektionen der Frau. Therapiewoche 10: 896–900
Roberts JA (1990) Pathogenesis of nonobstructive urinary tract infections in children. J Urol 144: 475–479
Robledo JA, Serrano A, Domingue GJ (1990) Outer membrane proteins of E. coli in the host-pathogen interaction in urinary tract infection. J Urol 143: 386–391
Schaeffer A, Jones J, Dunn J (1981) Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary tract infection. N Engl J Med 304: 1062–1066
Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, Rogatko A, Fair WR (1989) Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 320: 773–776
Schofer O, Ludwig K-H, Mannhardt W, Beetz R, Zepp F, Schulte-Wissermann H (1988) Antibacterial capacity of buccal epithelial cells from healthy donors and children with recurrent urinary tract infections. Eur J Pediatr 147: 229–232
Schoolnik GK (1989) How Escherichia coli infects the urinary tract. N Engl J Med 320: 804–805
Schulman CC, Corbusier A, Michiels H, Taenzer HJ (1993) Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol 150: 917–921
Schulte-Wissermann H, Mannhardt W, Schwarz J, Zepp F, Bitter-Sauermann D (1985) Comparison of the antibacterial effect of uroepithelial cells from healthy donors and children with asymptomatic bacteriuria. Eur J Pediatr 144: 230–233
Schwartzer T, Alcid DV, Numsuwan V, Gocke DJ (1988) Characterization of the human antibody re-sponse to an E. coli 0111:B4 (J5) vaccine. J Infect Dis 158: 1135–1136
Sloot N, Hacker J, Kreft B, Marre R (1992) Uropathogenität von Escherichia coli. Einfluß von Virulenzdeterminanten auf den Infektionsverlauf. Chemother J 1: 104–110
Smith J, Adkins M, McGreary D (1975) Local immune response in experimental pyelonephritis in the rabbit. Immunology 29: 1067–1076
Sobel JD, Kaye D (1985) Reduced uromucoid excretion in the elderly. J Infect Dis 152: 653
Sollid LM, Kvale D, Brantzaeg P, Markussen G, Thorsby E (1987) Interferon-g enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol 138: 4303
Srivenugopal K, Ali-Osman F (1990) Stimulation and inhibition of 1,3- bis (2-chloroethyl)-l-nitro- sourea-induced strand breaks and interstrand cross-linking in ColEl plasmid deoxyribonucleic acid by polyamines and inorganic cations. Biochem Pharmacol 40: 473–479
Svanborg-Eden C (1985) Urinary immunoglobulins in healthy individuals and children with acute pyelonephritis. Scand J Immunol 21: 305–313
Svanborg-Eden C, Svennerholm A-M (1978) Secretory IgA and IgG prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infect Immun 22: 790
Svanborg-Eden C, Briles D, HagbergL, McGhee J, Michalec S (1984) Genetic factors in host resistance to urinary tract infection. Infection 12: 118–123
Svenson SB, Källenius G (1986) The role of bacterial adherence in the initiation of clinical pyelonephritis. Year Book Medical Publishers, pp 245–257
Tammen H (1990) Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. Br J Urol 65: 6–9
Tjandrawinata R, Hewel L III., Byus C (1994) Regulation of putrescine export in lipopolysaccharide or IFN-g-activated murine monocytic-leukemic RAW 264 cells. J Immunol 154: 3039–3052
Trinchieri A, Brachesi L et al. (1990) Secretory immunoglobulin A and inhibitory activity of bacterial adherence to epithelial cells in urine from patients with urinary tract infections. Urol Res 18: 305–308
Tschäpe H (1992) Charakterisierung der Antibiotikaresistenz. Genotypanalysen von Bakterien zur epidemiologischen und ökologischen Charakterisierung. Chemother J 1: 50–57
Tullus K, Fituri O, Burman L, Wretlind B, Brauner A (1994) Interleukin-6 and interleukin-8 in the urine of children with acute pyelonephritis. Pediatr Nephrol 8: 280–284
Tunn U, Brühl P (1969) Experimentelle Pyelonephritis I: Komplement- und Antikörper-Titer bei nicht obstruktiver Enterokokken-Pyelonephritis. Klin Wochenschr 47: 479
Uehling DT, Jensen J, Balish E (1982) Vaginal immunization against UTI. J Urol 128: 1382–1384
Uehling DT (1986) Future approaches to the management of urinary tract infections. Urol Clin North Am 13: 4
Uehling DT (1988) This month in investigative urology: what makes bacteria stick to the bladder mucosa? J Urol 140: 749–758
Uehling DT, Hopkins WJ, Balish E (1990) Decreased immunologic responsiveness following intensified vaginal immunization against urinary tract infection. J Urol 143: 143–145
Virkola R, Westerlund B, Holthöfer H, Parkinnen J, Kekomäki M, Korhonen TK (1988) Binding characteristics of E. coli adhesins in human urinary bladder. Infect Immun 56: 2615–2622
Vosti K, Monto A, Rantz L (1965) Host-parasite interaction in patients with infections due to Escherichia coli. II. Serologic response of the host. J Lab Clin Med 66: 612–626
Wei T-F, Bujalowski W, Lohman T (1992) Cooperative binding of polyamines induces the Escherichia coli single-strand binding protein DANN-binding mode transitions. Biochemistry 31: 6166–6174
Wold AE, Mestecky J, Svanborg EC (1988) Agglutination of Escherichia coli by secretory IgA - a result of interaction between bacterial mannose-specific adhesins and immunoglobulin carbohydrate. Monogr Allergy 24: 307–309
Zasloff M (1987) Maganins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84: 5449–5453
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Brühl, P. (1999). Körpereigene Abwehrmechanismen bei Harnwegsinfektionen. In: Hofstetter, A. (eds) Urogenitale Infektionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59883-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-59883-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64165-7
Online ISBN: 978-3-642-59883-8
eBook Packages: Springer Book Archive